Thank you for visiting our
booth at ECCMID 2024
|
 |
|
|
Many people attended our integrated symposium - Molecular Diagnostics for High Burden Infectious Diseases: Assessing Usability Through Performance Testing
|
| We would like to extend our heartfelt gratitude for your participation. |
| During the symposium, 5 Leaders shared the evaluation results of using our molecular diagnostic systems for globally high burden infectious diseases. |
|
- Evaluating the Diagnostic Accuracy and Specificity of Point-of-Care system for Detecting M. tuberculosis, MDR-TB, and XDR-TB in Liquid Culture Samples, Highlighting its Specificity for MTB through NTM Non-Detection, as a Tool for Improved Tuberculosis Management
- New Insights in Romania’s TB screening: an innovative PCR technology with rapid and accurate results
- Clinical performance evaluation of Fully-Automated MDx system for hepatitis B virus monitoring
- Clinical performance evaluation of Fully-Automated system for molecular diagnosis of hepatitis C virus
- Verification of a new platform for HIV-1 quantitative assays
|
|
|
| We hope you had a great time and look forward to seeing you at ESCMID Global 2025.
|
You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.
|
|
|
|
